HI
CPRX

Horizon Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Horizon Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
4,567
-52,200
-92% -$1.54M ﹤0.01% 1068
2026
Q1 		$1.41M Buy
56,767
+4,340
+8% +$103K 0.02% 566
2025
Q4 		$1.22M Buy
52,427
+8,334
+19% +$186K 0.02% 581
2025
Q3 		$869K Sell
44,093
-5,562
-11% -$114K 0.01% 659
2025
Q2 		$1.08M Buy
+49,655
New +$1.17M 0.02% 548

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Horizon Investments's CPRX Position: Q2 2026 in Review

Horizon Investments reduced its Catalyst Pharmaceutical (CPRX) stake by 92% in Q2 2026, selling an estimated $1.54M and leaving 4,567 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Horizon Investments first reported a position in CPRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.41M in Q1 2026. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Horizon Investments held 4,567 shares of Catalyst Pharmaceutical worth $144K as of Q2 2026.
  • Horizon Investments sold 52,200 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.54M.
  • Catalyst Pharmaceutical made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1068 holding.
  • Horizon Investments first reported a position in Catalyst Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Horizon Investments's Catalyst Pharmaceutical position peaked at $1.41M in Q1 2026.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.